StockIQ.techPhathom Pharmaceuticals, Inc. (PHAT) Stock Analysis
Free AI-powered analysis and research for Phathom Pharmaceuticals, Inc. stock
Sector: Healthcare
Full PHAT report
Phathom Pharmaceuticals, Inc. (PHAT) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze PHAT Now →📰 Latest Update
What Phathom Pharmaceuticals (PHAT) Said on Its Q3 Earnings Call
Thu, October 29, 2026 at 9:14 PM UTC 3 min read
Phathom Pharmaceuticals (PHAT) reported its Q3 earnings, highlighting a significant increase in revenue driven by strong sales of its lead product, vonoprazan, for the treatment of acid-related disorders. The company also provided updates on its ongoing clinical trials and regulatory submissions, which could enhance its market position. For investors, these developments signal potential growth opportunities and reinforce confidence in Phathom's strategic direction and product pipeline.